Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

828 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Poor baseline immune function predicts an incomplete immune response to combination antiretroviral treatment despite sustained viral suppression.
Falster K, Petoumenos K, Chuah J, Mijch A, Mulhall B, Kelly M, Cooper DA; Australian HIV Observational Database. Falster K, et al. Among authors: cooper da. J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):307-13. doi: 10.1097/QAI.0b013e3181945ed4. J Acquir Immune Defic Syndr. 2009. PMID: 19194311 Free PMC article.
The TREAT Asia HIV Observational Database: baseline and retrospective data.
Zhou J, Kumarasamy N, Ditangco R, Kamarulzaman A, Lee CK, Li PC, Paton NI, Phanuphak P, Pujari S, Vibhagool A, Wong WW, Zhang F, Chuah J, Frost KR, Cooper DA, Law MG; TREAT Asia HIV Observational Database. Zhou J, et al. Among authors: cooper da. J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):174-9. doi: 10.1097/01.qai.0000145351.96815.d5. J Acquir Immune Defic Syndr. 2005. PMID: 15671802 Free PMC article.
The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection: final results from a randomized clinical trial (Pulse).
Bloch MT, Smith DE, Quan D, Kaldor JM, Zaunders JJ, Petoumenos K, Irvine K, Law M, Grey P, Finlayson RJ, McFarlane R, Kelleher AD, Carr A, Cooper DA. Bloch MT, et al. Among authors: cooper da. J Acquir Immune Defic Syndr. 2006 Jun;42(2):192-202. doi: 10.1097/01.qai.0000219779.50668.e6. J Acquir Immune Defic Syndr. 2006. PMID: 16688094 Clinical Trial.
Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia.
Wright ST, Law MG, Cooper DA, Keen P, McDonald A, Middleton M, Woolley I, Kelly M, Petoumenos K; Australian HIV Observational Database. Wright ST, et al. Among authors: cooper da. J Int AIDS Soc. 2015 Apr 10;18(1):19463. doi: 10.7448/IAS.18.1.19463. eCollection 2015. J Int AIDS Soc. 2015. PMID: 25865372 Free PMC article.
A randomized, multicenter, open-label study of poly-L-lactic acid for HIV-1 facial lipoatrophy.
Carey DL, Baker D, Rogers GD, Petoumenos K, Chuah J, Easey N, Machon K, Cooper DA, Emery S, Carr A; Facial LipoAtrophy Study in HIV Investigators. Carey DL, et al. Among authors: cooper da. J Acquir Immune Defic Syndr. 2007 Dec 15;46(5):581-9. doi: 10.1097/qai.0b013e318158bec9. J Acquir Immune Defic Syndr. 2007. PMID: 18193500 Clinical Trial.
828 results